Cargando…
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
Rationale: Androgen receptor splice variant 7 (AR-V7) is a leading cause of the development of castration-resistant prostate cancer (CRPC). However, the regulation and function of AR-V7 at levels of post-translational modifications in prostate cancer therapy remain poorly understood. Here, we conduc...
Autores principales: | Liao, Yuning, Liu, Yuan, Xia, Xiaohong, Shao, Zhenlong, Huang, Chuyi, He, Jinchan, Jiang, Lili, Tang, Daolin, Liu, Jinbao, Huang, Hongbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069092/ https://www.ncbi.nlm.nih.gov/pubmed/32206096 http://dx.doi.org/10.7150/thno.41849 |
Ejemplares similares
-
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer
por: Liu, Yuan, et al.
Publicado: (2021) -
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
por: Xia, Xiaohong, et al.
Publicado: (2021) -
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
por: Xia, Xiaohong, et al.
Publicado: (2019) -
USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36
por: Xia, Xiaohong, et al.
Publicado: (2020) -
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
por: Xia, Xiaohong, et al.
Publicado: (2020)